http://purl.org/np/RA8AbsRwXr5l1UYaV4KQkGpvqY09KkcYXO0sRqk3rtf5I RA8AbsRwXr

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo

https://orcid.org/0000-0003-4727-9435 Michel Dumontier

Michel Dumontier

2022-09-16T17:18:27Z

http://purl.org/np/RA8AbsRwXr5l1UYaV4KQkGpvqY09KkcYXO0sRqk3rtf5I RA8AbsRwXr

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#generatedAtTime generatedAtTime

2022-09-16T17:18:27Z

Michel Dumontier

2022-09-16T17:18:27Z

http://purl.org/np/RA8AbsRwXr5l1UYaV4KQkGpvqY09KkcYXO0sRqk3rtf5I RA8AbsRwXr

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

Fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD)

Michel Dumontier

2022-09-16T17:18:27Z

http://purl.org/np/RA8AbsRwXr5l1UYaV4KQkGpvqY09KkcYXO0sRqk3rtf5I RA8AbsRwXr

links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance

http://www.w3.org/ns/prov#hadPrimarySource hadPrimarySource

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439 drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439

Michel Dumontier

2022-09-16T17:18:27Z